Nutritional psychiatry, which explores how diet impacts mental well-being, is expanding its approach with potential new tools. Research suggests GLP-1 receptor agonists—a class of drugs originally developed for diabetes and weight management—could play a role in improving mood and cognitive function. Early studies indicate these medications may influence brain pathways linked to depression and anxiety, offering a fresh avenue for treatment. Scientists are now investigating whether dietary interventions combined with these drugs could enhance mental health outcomes.
Nutritional psychiatry uses specialized diets to address mental health problems. GLP-1s may be its next frontier.
